Siemens Healthineers Polska
Point-of-Care Testing
Rozwiązania do szybkich badań parametrów kardiologicznych
Systemy do badań parametrów sercowych
System diagnostyczny Stratus® CS Acute Care™

Stratus® CS 200 Acute Care™ Troponin Analyzer

The Stratus^® CS Analyzer* for acute care diagnostics provides quantitative cardiac assays for fast, accurate evaluation of patients presenting with suspected myocardial ischemia. Its efficiency and ease of use make it ideal for both point-of-care testing and lab applications.

Easy to use and ideal for all skill levels
Full cardiac menu including guideline acceptable troponin I and D-dimer (with pulmonary embolism exclusion)** assays
Results in as little as 14 minutes
Use in the acute care setting to decrease turnaround time, patient length of stay, and total patient costs

Stratus CS Acute Care Diagnostic System

Cechy i korzyści

Managing Chest Pain to Meet the Challenge

Each year, more than eight million patients visit emergency departments in the United States with chest pain suggestive of myocardial ischemia. Yet, in around 75% of cases, objective evidence of unstable coronary syndrome is lacking after the initial clinical and ECG evaluation.

Accelerated diagnostic protocols using biochemical markers and near-patient testing strategies with the Stratus^® CS analyzer can help address this challenge. Consequently, hospital stays—and the cost to manage both ACS-positive and ACS-negative patients—can be reduced.

Fast, informative results

Rapid turnaround time: 14 minutes to first result, and 4 minutes for each subsequent result
A broad menu of tests to support better chest pain differentiation from a single sample, on a single run, on a single instrument

	Troponin I – our guideline acceptable assay meets accreditation with an imprecision level of ≤10% at the 99th percentile of normal population.
	D-Dimer assay with clinically validated claim to exclude pulmonary embolism**
	NT-proBNP – aids in the diagnosis and assessment of severity of congestive heart failure and used for risk stratification of patients with acute coronary syndrome and heart failure
	Cardiophase^® hsCRP – helpful for assessing risk of future cardiovascular disease
	Quantitative ßhCG – early pregnancy detection to guide diagnostic testing decisions
	CKMB Mass – an alternative to Troponin I to aid in the diagnosis of acute myocardial infarction
	Myoglobin – an early biomarker to aid in the diagnosis of patients suspected of myocardial infarction

Easy-to-use in the Emergency Department, Coronary Care Unit, STAT Lab or Central Lab

Simple operation for all skill levels: load sample, rotor, TestPak™ Cartridge(s)—and press Start
System accepts blood directly from collection tube—no sample preparation, no manual dilutions
Integrated centrifuge spins whole blood to plasma and automatically pipettes to test cartridges—no user manipulation needed

Efficient and cost-effective

Eliminates manual intervention steps that prolong result turnaround
Single use packaging for tests, calibrators, and diluents reduce reagent waste
Select tests based on patient need—no fixed assay panels
System Check (electronic QC) reduces liquid QC frequency requirements

Compliant

Barcode readers and lockout features for near-patient testing compliance
Fully compliant with OSHA Bloodborne Pathogens Preamble
First to the market with a guideline acceptable troponin I assay with the low end precision to meet the 2012 ESC/ACC Guidelines

Extensive Support

Onsite training
Field service group
Technical telephone support

Testy

Assays In-Depth

Click below to learn more about each assay available on the Stratus CS analyzer.

Specyfikacje techniczne

System, Sample, and Reagent Specifications.

	Troponin-I	CK-MB	NT-proBNP	D-dimer	hsCRP	Myoglobin	ßhCG
Assay Range	^{0.03 - 50 ng/mL}	^{0.3 –150 ng/mL (µg/L)}	^{15 –20000 pg/mL}	^{6 – 5000 ng/mL (µg/L) FEU}	^{0.1 –50 mg/L}	^{1– 900 ng/mL (}^µg/L)	^{0.5 –1250 mIU/mL (IU/L)}
Sensitivity	^{<0.03 ng/mL}	^{0.3 ng/mL}	^{15.0 pg/mL}	^{6 ng/mL FEU}	^{0.10 mg/L}	^1.0^ng/mL	^{0.5 mIU/mL}
Reproducibility (CV)	^{10% at 0.06 ng/mL}	^{4.0% at 3.7 ng/mL}	^{4.4% at 96.6 pg/mL}	^{4.1% at 412 ng/mL}	^{6.8% at 1.16 mg/L}	^{3.4% at 56 ng/mL}	^{2.5% at 27.1 mIU/mL†}
Calibration Stability	^{60 days}	^{60 days}	^{30 days}	^{60 days}	^{60 days}	^{60 days}	^{90 days}
DilPak™ Automatic Dilution	^Yes	^Yes	^Yes	^Yes	—	^Yes	^Yes
Sodium Heparin Tubes	^Yes	^Yes	^Yes	—	^Yes	^Yes	^Yes
Lithium Heparin Tubes	^Yes	^Yes	^Yes	^Yes	^Yes	^Yes	^Yes
Sodium Citrate Tubes	—	—	—	^Yes	—	—	—

† Total precision measured with Bio-Rad Control Liquichek™ Level 2. Liquichek is a trademark of Bio-Rad.

Please refer to the assay insert sheets or operator’s guide for more detailed information.

Automatic Alignment
Level-sensing capabilities automatically align to each TestPak and module

Computer Interface Specifications
Uni-directional through serial port

Environmental Specifications
Room Temperature: 15-30°C (65-85°F)
Humidity: 20–80%

Waste Disposal
All hazardous materials are contained within a disposable waste liner

Centrifuge Speed
Microprocessor-verified between 18,000 and 22,000 rpm

Sample and TestPak Identification
Universal bar code reader

Reagent Capacity
Single-use assay cartridges

Assay Technology
Dendrimer enhanced radial partition immunoassay

Quality Control

Daily system check (electronic QC) with programmable time lockout
Liquid controls are processed after calibration, upon receipt of a previously calibrated lot of reagents or whenever the site wishes to verify performance, and according to local, state, and/or federal regulations
On-board “QC Required” alert for a time element and/ or range check

Software Features